Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2006326564 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Mastracchio, Anthony; Edmondson, Scott D.; Cox, Jason M.

Agent Spruson & Ferguson

Pub. Number AU-B-2006326564

PCT Pub. Number WO2007/070434

Priority 60/750,135 14.12.05 US

Filing date 8 December 2006

Wipo publication date 21 June 2007

Acceptance publication date 23 June 2011

International Classifications

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A01N 43/40 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/45 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/070434 Priority application(s): WO2007/070434

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

23 June 2011 Application Accepted

  Published as AU-B-2006326564

20 October 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006326580-Fast-acting oral peptide pharmaceutical products

2006326561-Process for treating a cellulose-lignin pulp